The Food and Drug Administration has been deciding upon whether to put criminal charges on Johnson & Johnson for the two faults reported in the Company. Recently, one of its manufacturing units was spotted for the production of children's Tylenol and it recalled over-the-counter kids' medicines.
FDA's principal deputy commissioner, Joshua Sharfstein, shared that J&J's McNeil Consumer Healthcare unit was reported to have non compliant patterns in good manufacturing areas. Various regulators have been scrutinizing its different units via seizure, injunction or criminal penalties.
He added that FDA's criminal investigations office has been probing the matter.
Thursday’s hearings crept more controversies when the lawmakers pressurized the J&J officials to explain the causes of the contractors sending across workers to buy back its products from all the markets.
Further, under this pressure, the Company had ordered a recall of 88,104 packages of Motrin in July 2009.
Dr. Sharfstein told that the FDA is doing well with the Company, in spite of a number of faults reported in the Company earlier.
The hearing chiefly addressed the issues arousing at J&J's McNeil unit which had been responsible for managing the plant at Fort Washington, Pa.